» Articles » PMID: 37688650

Associations Amongst Genes, Molecules, Cells, and Organs in Breast Cancer Metastasis

Overview
Specialty Oncology
Date 2023 Sep 9
PMID 37688650
Authors
Affiliations
Soon will be listed here.
Abstract

This paper is a cross fertilization of ideas about the importance of molecular aspects of breast cancer metastasis by basic scientists, a pathologist, and clinical oncologists at the Henry Ford Health symposium. We address four major topics: (i) the complex roles of lymphatic endothelial cells and the molecules that stimulate them to enhance lymph node and systemic metastasis and influence the anti-tumor immunity that might inhibit metastasis; (ii) the interaction of molecules and cells when breast cancer spreads to bone, and how bone metastases may themselves spread to internal viscera; (iii) how molecular expression and morphologic subtypes of breast cancer assist clinicians in determining which patients to treat with more or less aggressive therapies; (iv) how the outcomes of patients with oligometastases in breast cancer are different from those with multiple metastases and how that could justify the aggressive treatment of these patients with the hope of cure.

Citing Articles

Cancer metastasis through the lymphatic versus blood vessels.

Leong S, Witte M Clin Exp Metastasis. 2024; 41(4):387-402.

PMID: 38940900 PMC: 11374872. DOI: 10.1007/s10585-024-10288-0.


Truncated O-glycosylation in metastatic triple-negative breast cancer reveals a gene expression signature associated with extracellular matrix and proteolysis.

Festari M, Jara E, Costa M, Iriarte A, Freire T Sci Rep. 2024; 14(1):1809.

PMID: 38245559 PMC: 10799929. DOI: 10.1038/s41598-024-52204-2.

References
1.
Giaquinto A, Sung H, Miller K, Kramer J, Newman L, Minihan A . Breast Cancer Statistics, 2022. CA Cancer J Clin. 2022; 72(6):524-541. DOI: 10.3322/caac.21754. View

2.
Leonard-Murali S, Nathanson S, Springer K, Baker P, Susick L . Early breast cancer survival of black and white American women with equal diagnostic and therapeutic management. Eur J Surg Oncol. 2022; 49(3):583-588. PMC: 9974573. DOI: 10.1016/j.ejso.2022.11.101. View

3.
Dieterich L, Tacconi C, Ducoli L, Detmar M . Lymphatic vessels in cancer. Physiol Rev. 2022; 102(4):1837-1879. DOI: 10.1152/physrev.00039.2021. View

4.
Stacker S, Williams S, Karnezis T, Shayan R, Fox S, Achen M . Lymphangiogenesis and lymphatic vessel remodelling in cancer. Nat Rev Cancer. 2014; 14(3):159-72. DOI: 10.1038/nrc3677. View

5.
Dieterich L, Detmar M . Tumor lymphangiogenesis and new drug development. Adv Drug Deliv Rev. 2015; 99(Pt B):148-160. DOI: 10.1016/j.addr.2015.12.011. View